Insider Selling: HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Sells 477 Shares of Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank sold 477 shares of the firm’s stock in a transaction dated Tuesday, January 10th. The stock was sold at an average price of $21.90, for a total transaction of $10,446.30. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $342.25 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $84.26 billion, a PE ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The stock’s fifty day simple moving average is $324.53 and its 200 day simple moving average is $341.56.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company posted $5.90 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

Analysts Set New Price Targets

Several research firms have recently weighed in on HCA. KeyCorp lowered their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Bank of America cut their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Royal Bank of Canada dropped their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $385.67.

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Sanders Capital LLC raised its holdings in HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock worth $3,498,417,000 after acquiring an additional 116,826 shares in the last quarter. First Eagle Investment Management LLC boosted its holdings in shares of HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after buying an additional 23,177 shares during the last quarter. Geode Capital Management LLC increased its holdings in HCA Healthcare by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after buying an additional 50,321 shares during the last quarter. Capital World Investors grew its position in shares of HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock valued at $878,975,000 after acquiring an additional 19,121 shares during the period. Finally, Norges Bank bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $840,286,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.